Dissemin is shutting down on January 1st, 2025

Published in

Wiley, Journal of Parenteral and Enteral Nutrition, 4(46), p. 923-935, 2021

DOI: 10.1002/jpen.2224

Links

Tools

Export citation

Search in Google Scholar

Bile acid–farnesoid X receptor–fibroblast growth factor 19 axis in patients with short bowel syndrome: The randomized, glepaglutide phase 2 trial

Journal article published in 2021 by Mark Krogh Hvistendahl ORCID, Rahim Mohammad Naimi ORCID, Svend Høime Hansen, Jens Frederik Rehfeld, Hannelouise Kissow ORCID, Jens Pedersen, Lars Ove Dragsted, David Peick Sonne ORCID, Filip Krag Knop, Palle Bekker Jeppesen ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO